Or
Orphazyme
Copenhagen DKFounded 200950 employees
Private CapbiotechAcquiredRare Disease
Platform: HSP70 Induction
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zorirapivir | ORP-9034 | NDA/BLA | 2 | IL-17A | NB | ||
| Zenotuximab | ORP-6585 | Phase 2/3 | 1 | FGFR | RACRC | ||
| ORP-8634 | ORP-8634 | Phase 1/2 | 1 | KRASG12D | CFHuntington's |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)